Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11841363 ZnT8 assays for drug development and pharmaceutical compositions

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Dax Fu0

Date of Patent

December 12, 2023

0

Patent Application Number

172429380

Date Filed

April 28, 2021

0

Patent Citations

US Patent 8563291 Method of constructing recombinant proteoliposome for diagnostic use

0

US Patent 11016085 ZNT8 assays for drug development and pharmaceutical compositions

0

US Patent 6881557 Super humanized antibodies

0

US Patent 9568482 Antibodies specific for ZNT8

0

Patent Citations Received

US Patent 12103968 Antibodies to human ZnT8

0

Patent Primary Examiner

Yevgeny Valenrod

0

CPC Code

0

0

0

0

Patent abstract

The present invention describes methods of identifying drugs for the treatment or prevention of diabetes by measuring the activity of the human zinc transporter ZnT8 and pharmaceutical compositions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11841363 ZnT8 assays for drug development and pharmaceutical compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool